BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes
BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.
October 15, 2024
by PharmaSources
BD Showcases Latest Drug Delivery Innovations at CPhI Milan 2024
BD (Becton, Dickinson and Company will highlight its newest innovations in drug delivery systems at CPhI Milan 2024
October 14, 2024
by Pharmasources
BD to Highlight its Deep Commitment to Drug Delivery Innovation at Pharmapack
A leading global medical technology company, will showcase numerous drug delivery innovations at Pharmapack 2024, which will take place on January 24-25, 2024 at Paris Expo, Porte de Versailles, in Paris.
January 15, 2024
by B3C newswire
BD to Showcase its Commitment to Drug Delivery and Packaging Innovation at CPhI 2023 Conference
BD (Becton, Dickinson and Company), a leading global medical technology company, is excited to showcase at CPhI Barcelona 2023.
November 6, 2023
by B3C newswire
BD Launches Plunger Stopper in Partnership with Aptar Pharma to Enhance Biologic Drug Delivery
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD SCF™ PremiumCoat®† Plunger Stopper in partnership with Aptar Pharma...
October 15, 2021
by B3Cnewswire
Pharmapack 2021: Pre-filled syringe technology could provide answers to future mass vaccination challenges, says BD
Speaking at the Pharmapack Europe 2021 online conference in the session Responding to the Vaccine Delivery Challenges, Marie-Liesse Le Crofec, Global Portfolio Marketing Head...
October 13, 2021
by CPhIonline
BD Completes Study Investigating Performance of Glass Prefillable Syringes (PFS) in Deep Cold Storage
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, completed a preliminary study investigating the impact of deep cold storage (-20°C and -40°C) on glass PFS.
September 28, 2021
by B3Cnewswire
BD and CerTest Biotec Announce CE Mark for Molecular Test to Detect, Identify Certain SARS-CoV-2 Variants
BD (Becton, Dickinson and Company) (NYSE: BDX) today announced the CE mark for a molecular test that can detect and distinguish between the Alpha (B.1.1.7), Beta (B.1.351) and Gamma (P.1) SARS-CoV-2 variants.
August 9, 2021
by b3cnewswire
BD Hits 2 Billion Injection Device Milestone for COVID-19 Vaccinations
BD (Becton, Dickinson and Company) has received pandemic orders for needles and syringes totaling 2 billion injection devices to support global COVID-19 vaccination efforts.
June 15, 2021
by contractpharma
BD to Build New €165 Million Manufacturing Facility in Zaragoza, Spain To Support Ongoing Strong Growth of Pre-Filled Drug Delivery Business
New plant will produce drug delivery devices, employ 150 people in 2024 and up to 600 when full operations start in 2030
May 21, 2021
by b3cnewswire
BD to Build $200M PFS Mfg. Facility in Spain
New site is part of a $1.2 billion investment over four years to expand and upgrade manufacturing capacity and technology for pre-fillable syringes.
May 19, 2021
by contractpharma
FDA Advises Health Care Professionals Not to Use ChloraPrep 3 mL BD Applicators
The U.S. Food and Drug Administration (FDA) advises health care professionals not to use ChloraPrep 3 mL applicators manufactured by BD (Becton, Dickinson and Company), due to microbial contamination risks.
March 26, 2021
by americanpharmaceuticalreview